Accessibility Menu
 
Tristel Plc logo

Tristel Plc

(LSE) TSTL

Current Price$387.00
Market Cap$18.33B
Since IPO (2005)+1,206%
5 Year-44%
1 Year+21%
1 Month-1%

Tristel Plc Financials at a Glance

Market Cap

$18.33B

Revenue (TTM)

$93.10M

Net Income (TTM)

$14.00M

EPS (TTM)

$16.24

P/E Ratio

23.21

Dividend

$14.20

Beta (Volatility)

0.04 (Low)

Price

$387.00

Volume

50,927

Open

$385.00

Previous Close

$387.00

Daily Range

$375.00 - $390.00

52-Week Range

$318.00 - $445.00

TSTL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tristel Plc

Industry

Healthcare Equipment and Supplies

Employees

267

CEO

Matthew Giovanni Sassone

Headquarters

Newmarket, CB8 7NY, GB

TSTL Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

20%

Net Income Margin

16%

Return on Equity

24%

Return on Capital

25%

Return on Assets

17%

Earnings Yield

4.31%

Dividend Yield

0.04%

Payout Ratio

86.18%

Stock Overview

Market Cap

$18.33B

Shares Outstanding

47.93M

Volume

50.93K

Short Interest

0.00%

Avg. Volume

133.50K

Financials (TTM)

Gross Profit

$37.94M

Operating Income

$8.40M

EBITDA

$11.47M

Operating Cash Flow

$10.32M

Capital Expenditure

$857.00K

Free Cash Flow

$9.46M

Cash & ST Invst.

$12.84M

Total Debt

$5.88M

Tristel Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$25.65M

+22.5%

Gross Profit

$19.59M

+11.7%

Gross Margin

76.38%

N/A

Market Cap

$18.33B

N/A

Market Cap/Employee

$78.69M

N/A

Employees

233

N/A

Net Income

$3.95M

+28.3%

EBITDA

$6.51M

+50.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$7.46M

+55.1%

Accounts Receivable

$8.79M

+28.3%

Inventory

$4.32M

-2.9%

Long Term Debt

$4.71M

-8.3%

Short Term Debt

$1.11M

+36.4%

Return on Assets

17.31%

N/A

Return on Invested Capital

25.03%

N/A

Free Cash Flow

$5.10M

-1.4%

Operating Cash Flow

$5.41M

+0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BXP.LBeximco Pharmaceuticals Limited
$42.50+0.00%
ANCR.LAnimalcare Group plc
$245.00-0.41%
OPT.LOptima Health plc
$180.50+0.00%
DXRX.LDiaceutics PLC
$161.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About TSTL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.